October 26th, 2020
BIO-Europe is the largest partnering conference in Europe dedicated to the global biotechnology industry. On this occasion, it will be held in digital format from October 26 to 29. The conference brings together delegates from the entire value chain of the biotech industry, who come to event to identify, negotiate and start strategic relationships that can boost their business. This edition will again attract about 3,700 participants from 60 countries, representing about 2,000 companies.

PROALT will participate in the partnering event and will met during these days with worldwide pharma companies developing therapeutic antibodies and other potential technological partners, including VC investors.

The company will present the latest results of the successful efficacy studies conducted in animal models of metastatic colorectal cancer (mCRC) with the most advanced therapeutic product PA-0661, a monoclonal antibody in pre-clinical phase.